Immunovia AB (publ) (0G8X.L)
LSE - LSE Delayed Price. Currency in SEK
Add to watchlist
At close: 11:13AM BST
| Previous Close | 1.4680 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 21,015 |
| Market Cap | 270,383 |
| Beta (5Y Monthly) | 2.73 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.8050 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireImmunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
Immunovia (NASDAQ: IMMNOV) (STO: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, announces today that the company has successfully developed accurate and precise assays to measure targeted proteins for its next-generation test.
PR NewswireImmunovia announces updated financial calendar
Immunovia (IMMNOV: Nasdaq) (IMMNOV: Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
PR NewswireImmunovia Publishes Full Year Report for 2023
Immunovia Publishes Full Year Report for 2023
© 2024 Yahoo. All rights reserved.